JY
KPRX icon

Jeff Yass’s Kiora Pharmaceuticals KPRX Stock Holding History

Jeff Yass’s Portfolio KPRX Stock Details KPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11,382
Closed -$41.7K – 12746
2024
Q3 		$41.7K Buy
+11,382
New +$44.4K ﹤0.01% 11448
2022
Q2 		– Sell
-31
Closed -$7K – 13452
2022
Q1 		$7K Buy
+31
New +$8.11K ﹤0.01% 12787
2019
Q3 		– Sell
-41
Closed -$53K – 10530
2019
Q2 		$53K Buy
+41
New +$60.5K ﹤0.01% 9830
2018
Q4 		– Sell
-13
Closed -$22K – 9488
2018
Q3 		$22K Buy
+13
New +$34.9K ﹤0.01% 8985
2016
Q2 		– Sell
-2
Closed -$35K – 8963
2016
Q1 		$35K Buy
+2
New +$30.9K ﹤0.01% 8729

Other funds holding KPRX

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return

Jeff Yass's KPRX Position: Q4 2024 in Review

Jeff Yass sold out of Kiora Pharmaceuticals (KPRX) in Q4 2024, closing a stake of 11,382 shares — an estimated $41.7K sold.

Jeff Yass first reported a position in KPRX in Q1 2016 and held it in 5 quarters. The position peaked at $53K in Q2 2019. 16 funds tracked by Wall St. Rank hold KPRX as of Q4 2024.

  • Jeff Yass reported no remaining Kiora Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Jeff Yass sold 11,382 Kiora Pharmaceuticals shares in Q4 2024, an estimated $41.7K.
  • Jeff Yass first reported a position in Kiora Pharmaceuticals in Q1 2016 and held it in 5 quarters.
  • Jeff Yass's Kiora Pharmaceuticals position peaked at $53K in Q2 2019.
  • 16 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q4 2024.

Based on Susquehanna International Group's 13F filing for Q4 2024, filed 14 Feb 2025.